SERA · NASDAQ · Medical - Diagnostics & Research

Sera (SERA)

Develops blood tests and predictive analytics for earlier assessment of spontaneous preterm-birth risk.

$2.13
After hours−0.01 (−0.47%)
At close$2.14(+0.94%)